Analyst Ratings (USA)
Today’s analyst updates suggest a selective outlook, with strength in defence, pharmaceuticals and parts of software and financial services. Technology remains divided, as upgrades and higher targets contrast with cuts across several semiconductor and cloud infrastructure names. Restaurants, autos and streaming attracted greater caution, while banks and utilities showed mixed revisions. Overall, the ratings favour individual opportunities rather than broad confidence across the market.
Updates (391)
3M (MMM) — Bernstein maintained its Market Perform rating and raised its price target to US$197.00 from US$171.00.
3M (MMM) — Citigroup maintained its Neutral rating.
3M (MMM) — Deutsche Bank maintained its Hold rating.
3M (MMM) — Jefferies maintained its Hold rating and set a US$186.00 price target.
3M (MMM) — JPMorgan maintained its Overweight rating and raised its price target to US$191.00 from US$185.00.
3M (MMM) — Raymond James maintained its Market Perform rating.
3M (MMM) — RBC Capital Markets maintained its Underperform rating and raised its price target to US$135.00 from US$132.00.
3M (MMM) — UBS maintained its Buy rating.
AbbVie (ABBV) — Barclays maintained its Overweight rating and raised its price target to US$325.00 from US$300.00.
Abivax (ABVX) — Piper Sandler maintained its Overweight rating.
Abivax (ABVX) — Wedbush maintained its Neutral rating and lowered its price target to US$96.00 from US$118.00.
Accenture (ACN) — Baird downgraded the stock to Neutral from Outperform and raised its price target to US$252.00 from US$245.00.
Advanced Micro Devices (AMD) — Susquehanna maintained its Positive rating and raised its price target to US$620.00 from US$550.00.
AGNC Investment (AGNC) — Barclays maintained its Equal Weight rating and lowered its price target to US$9.00 from US$10.00.
AGNC Investment (AGNC) — RBC Capital Markets maintained its Outperform rating and lowered its price target to US$10.00 from US$12.00.
AGNC Investment (AGNC) — Wells Fargo maintained its Overweight rating and lowered its price target to US$10.00 from US$11.00.
Agnico Eagle Mines (AEM) — JPMorgan maintained its Neutral rating and raised its price target to US$190.00 from US$179.00.
AgomAb Therapeutics (AGMB) — H.C. Wainwright maintained its Buy rating.
AgomAb Therapeutics (AGMB) — Johnson Rice maintained its Buy rating.
Agree Realty (ADC) — Baird maintained its Outperform rating and lowered its price target to US$76.00 from US$77.00.
Agree Realty (ADC) — BNP Paribas Exane maintained its Neutral rating and lowered its price target to US$74.00 from US$84.00.
Agree Realty (ADC) — Stifel maintained its Buy rating and lowered its price target to US$76.50 from US$81.50.
AIR Global (AIIR) — Roth Capital initiated coverage with a Buy rating and set a US$11.50 price target.
Akamai Technologies (AKAM) — Piper Sandler maintained its Overweight rating and lowered its price target to US$120.00 from US$158.00.
Align Technology (ALGN) — Piper Sandler maintained its Overweight rating and lowered its price target to US$205.00 from US$235.00.
Ally Financial (ALLY) — Barclays maintained its Equal Weight rating and lowered its price target to US$48.00 from US$56.00.
Ally Financial (ALLY) — Deutsche Bank set a US$56.00 price target.
Ally Financial (ALLY) — Evercore ISI set a US$40.00 price target.
Ally Financial (ALLY) — JPMorgan maintained its Overweight rating and raised its price target to US$44.00 from US$43.00.
Ally Financial (ALLY) — TD Cowen maintained its Buy rating and lowered its price target to US$52.00 from US$54.00.
Ameren (AEE) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$109.00 from US$108.00.
American Electric Power (AEP) — Morgan Stanley maintained its Overweight rating and raised its price target to US$130.00 from US$128.00.
Amgen (AMGN) — Barclays maintained its Equal Weight rating and raised its price target to US$400.00 from US$380.00.
Amphenol (APH) — Erste Group initiated coverage with a Buy rating.
A. O. Smith (AOS) — Oppenheimer maintained its Outperform rating and lowered its price target to US$72.00 from US$75.00.
AppFolio (APPF) — Keefe, Bruyette & Woods maintained its Outperform rating and raised its price target to US$255.00 from US$233.00.
Apple (AAPL) — Morgan Stanley maintained its Overweight rating.
Apple Hospitality REIT (APLE) — JPMorgan maintained its Neutral rating and raised its price target to US$17.00 from US$16.00.
Applied Digital (APLD) — Roth Capital resumed coverage with a Buy rating and set a US$35.00 price target.
Arcus Biosciences (RCUS) — Citigroup maintained its Buy rating.
Arcus Biosciences (RCUS) — Truist Securities maintained its Buy rating and raised its price target to US$41.00 from US$40.00.
Arcus Biosciences (RCUS) — Wedbush maintained its Outperform rating and raised its price target to US$49.00 from US$43.00.
Atlantic Union Bankshares (AUB) — Piper Sandler maintained its Overweight rating and lowered its price target to US$45.00 from US$47.00.
Atlantic Union Bankshares (AUB) — TD Cowen maintained its Buy rating and lowered its price target to US$43.00 from US$44.00.
Atlassian (TEAM) — Truist Securities maintained its Buy rating and raised its price target to US$250.00 from US$185.00.
Atmos Energy (ATO) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$182.00 from US$179.00.
AtriCure (ATRC) — Citigroup maintained its Market Outperform rating.
AtriCure (ATRC) — Citizens JMP maintained its Market Outperform rating and raised its price target to US$68.00 from US$52.00.
AtriCure (ATRC) — UBS downgraded the stock to Sell from Buy.
Aurinia Pharmaceuticals (AUPH) — TD Cowen maintained its Buy rating and raised its price target to US$18.00 from US$17.00.
Bancorp (TBBK) — Stephens maintained its Equal Weight rating and set a US$59.00 price target.
Barrick Mining (B) — JPMorgan maintained its Overweight rating and raised its price target to US$55.00 from US$52.00.
BBB Foods (TBBB) — UBS maintained its Buy rating and set a US$69.00 price target.
BETA Technologies (BETA) — Needham maintained its Buy rating and set a US$34.00 price target.
Biogen (BIIB) — TD Cowen maintained its Buy rating and raised its price target to US$250.00 from US$225.00.
BioMarin Pharmaceutical (BMRN) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$122.00 from US$124.00.
Blackstone (BX) — BMO Capital Markets maintained its Outperform rating and set a US$130.00 price target.
Block (XYZ) — RBC Capital Markets maintained its Outperform rating and set a US$95.00 price target.
Bloom Energy (BE) — BMO Capital Markets maintained its Outperform rating and set a US$260.00 price target.
BOK Financial (BOKF) — Stephens maintained its Equal Weight rating and lowered its price target to US$141.00 from US$148.00.
Braze (BRZE) — Citigroup downgraded the stock to Neutral from Buy and lowered its price target to US$47.50 from US$48.00.
Braze (BRZE) — Mizuho set a US$47.50 price target.
Braze (BRZE) — Raymond James downgraded the stock to Market Perform from Outperform.
BridgeBio Oncology Therapeutics (BBOT) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$13.00.
BridgeBio Pharma (BBIO) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$87.00 from US$97.00.
Brinker International (EAT) — Wells Fargo maintained its Overweight rating and lowered its price target to US$270.00 from US$280.00.
CACI International (CACI) — Cantor Fitzgerald maintained its Overweight rating and raised its price target to US$785.00 from US$675.00.
Capital One Financial (COF) — Barclays maintained its Overweight rating and raised its price target to US$238.00 from US$237.00.
Capital One Financial (COF) — BMO Capital Markets maintained its Market Perform rating and raised its price target to US$225.00 from US$219.00.
Capital One Financial (COF) — Citigroup maintained its Buy rating.
Capital One Financial (COF) — JPMorgan maintained its Overweight rating and raised its price target to US$241.00 from US$227.00.
Capital One Financial (COF) — Piper Sandler maintained its Overweight rating and raised its price target to US$269.00 from US$260.00.
Capital One Financial (COF) — TD Cowen maintained its Buy rating and raised its price target to US$250.00 from US$242.00.
Casella Waste Systems (CWST) — JPMorgan maintained its Neutral rating and raised its price target to US$99.00 from US$91.00.
Casella Waste Systems (CWST) — UBS downgraded the stock to Neutral from Buy and lowered its price target to US$95.00 from US$122.00.
CAVA Group (CAVA) — TD Cowen maintained its Buy rating and lowered its price target to US$78.00 from US$85.00.
Celcuity (CELC) — TD Cowen maintained its Buy rating and set a US$145.00 price target.
CenterPoint Energy (CNP) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$39.00 from US$38.00.
Centrus Energy (LEU) — H.C. Wainwright maintained its Buy rating and set a US$300.00 price target.
Chagee (CHA) — Jefferies upgraded the stock to Buy from Hold and set a US$14.90 price target.
Charles Schwab (SCHW) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$132.00 from US$141.00.
Cheesecake Factory (CAKE) — Wells Fargo maintained its Equal Weight rating and raised its price target to US$110.00 from US$105.00.
Chilwa Minerals (CHWM) — Maxim Group set a US$11.00 price target.
Chipotle Mexican Grill (CMG) — TD Cowen downgraded the stock to Hold from Buy and lowered its price target to US$32.00 from US$44.00.
Chipotle Mexican Grill (CMG) — Wells Fargo maintained its Overweight rating and lowered its price target to US$40.00 from US$45.00.
Choice Hotels International (CHH) — JPMorgan maintained its Neutral rating and raised its price target to US$121.00 from US$119.00.
Chubb (CB) — Cantor Fitzgerald maintained its Neutral rating and set a US$333.00 price target.
Chubb (CB) — Citigroup maintained its Market Outperform rating.
Churchill Downs (CHDN) — Susquehanna maintained its Positive rating and lowered its price target to US$115.00 from US$124.00.
Circle Internet Group (CRCL) — Needham maintained its Buy rating and raised its price target to US$134.00 from US$130.00.
Cirrus Logic (CRUS) — Barclays downgraded the stock to Underweight from Equal Weight and set a US$95.00 price target.
Cirrus Logic (CRUS) — Susquehanna maintained its Positive rating and lowered its price target to US$170.00 from US$200.00.
Clean Harbors (CLH) — UBS upgraded the stock to Buy from Neutral and raised its price target to US$375.00 from US$325.00.
Clean Harbors (CLH) — William Blair downgraded the stock to Neutral from Outperform.
Clearway Energy (CWEN) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$52.00 from US$58.00.
Clearway Energy (CWEN) — UBS set a US$38.00 price target.
CMS Energy (CMS) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$73.00 from US$77.00.
Coinbase Global (COIN) — Needham maintained its Buy rating and raised its price target to US$205.00 from US$200.00.
Commerce Bancshares (CBSH) — Piper Sandler maintained its Neutral rating and lowered its price target to US$60.50 from US$63.00.
Commerce Bancshares (CBSH) — Stephens maintained its Equal Weight rating and lowered its price target to US$62.00 from US$64.00.
Compass (COMP) — Zelman & Associates changed its rating to Outperform from Buy.
Corebridge Financial (CRBG) — TD Cowen maintained its Buy rating and raised its price target to US$40.00 from US$38.00.
CoreWeave (CRWV) — Piper Sandler maintained its Overweight rating and lowered its price target to US$124.00 from US$153.00.
Corning (GLW) — JPMorgan maintained its Neutral rating and lowered its price target to US$165.00 from US$170.00.
Costco Wholesale (COST) — CICC Research initiated coverage with an Outperform rating and set a US$1,050.00 price target.
Crown (CCK) — Citigroup maintained its Buy rating.
Crown (CCK) — UBS maintained its Neutral rating.
Cytosorbents (CTSO) — WBB Securities initiated coverage with a Speculative Buy rating and set a US$9.50 price target.
DaVita (DVA) — TD Cowen maintained its Buy rating.
DigitalOcean (DOCN) — Piper Sandler upgraded the stock to Overweight from Neutral and lowered its price target to US$126.00 from US$142.00.
Dime Community Bancshares (DCOM) — Keefe, Bruyette & Woods maintained its Outperform rating and raised its price target to US$49.00 from US$47.00.
Dime Community Bancshares (DCOM) — Piper Sandler maintained its Overweight rating and raised its price target to US$47.00 from US$45.00.
DoorDash (DASH) — BTIG Research maintained its Buy rating and set a US$225.00 price target.
DTE Energy (DTE) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$139.00 from US$141.00.
DT Midstream (DTM) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$164.00 from US$170.00.
Duke Energy (DUK) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$128.00 from US$127.00.
Duos Technologies Group (DUOT) — Cantor Fitzgerald maintained its Overweight rating and set a US$24.00 price target.
Dutch Bros (BROS) — TD Cowen maintained its Buy rating and lowered its price target to US$55.00 from US$59.00.
Dutch Bros (BROS) — Wells Fargo maintained its Overweight rating and lowered its price target to US$55.00 from US$70.00.
Dynatrace (DT) — BTIG Research maintained its Buy rating and raised its price target to US$73.00 from US$62.00.
Dynatrace (DT) — Truist Securities maintained its Buy rating and raised its price target to US$70.00 from US$60.00.
East West Bancorp (EWBC) — Morgan Stanley maintained its Overweight rating and raised its price target to US$168.00 from US$164.00.
East West Bancorp (EWBC) — TD Cowen maintained its Buy rating and raised its price target to US$153.00 from US$150.00.
eBay (EBAY) — Erste Group initiated coverage with a Buy rating.
Edison International (EIX) — Morgan Stanley maintained its Underweight rating and raised its price target to US$62.00 from US$60.00.
e.l.f. Beauty (ELF) — Deutsche Bank maintained its Hold rating and set a US$105.00 price target.
Eli Lilly and Company (LLY) — Leerink Partners maintained its Outperform rating and raised its price target to US$1,316.00 from US$1,309.00.
Energy Vault (NRGV) — Citigroup maintained its Buy rating.
Enphase Energy (ENPH) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to US$28.00 from US$37.00.
Entergy (ETR) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$101.00 from US$98.00.
Equifax (EFX) — BMO Capital Markets maintained its Market Perform rating and raised its price target to US$175.00 from US$160.00.
Equifax (EFX) — Deutsche Bank maintained its Buy rating and set a US$201.00 price target.
Equifax (EFX) — Needham maintained its Buy rating and raised its price target to US$210.00 from US$190.00.
Equifax (EFX) — Stifel maintained its Buy rating and lowered its price target to US$217.00 from US$235.00.
Equifax (EFX) — UBS maintained its Buy rating.
Equity Lifestyle Properties (ELS) — Baird maintained its Outperform rating and lowered its price target to US$71.00 from US$74.00.
ESAB (ESAB) — Oppenheimer maintained its Outperform rating and lowered its price target to US$110.00 from US$135.00.
eToro Group (ETOR) — Needham maintained its Buy rating and lowered its price target to US$54.00 from US$55.00.
Exelon (EXC) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$49.00 from US$50.00.
Fabrinet (FN) — Susquehanna maintained its Positive rating and lowered its price target to US$600.00 from US$850.00.
Fastenal (FAST) — Argus maintained its Buy rating and raised its price target to US$59.00 from US$55.00.
Fidelity National Financial (FNF) — Stephens maintained its Overweight rating and lowered its price target to US$50.00 from US$55.00.
Fifth Third Bancorp (FITB) — Evercore ISI upgraded the stock to Outperform from In-line and set a US$60.00 price target.
Fifth Third Bancorp (FITB) — Stephens maintained its Equal Weight rating and lowered its price target to US$59.00 from US$61.00.
FirstEnergy (FE) — Morgan Stanley maintained its Overweight rating and raised its price target to US$50.00 from US$49.00.
First United (FUNC) — Raymond James maintained its Outperform rating.
First United (FUNC) — UBS upgraded the stock to Buy.
First Watch Restaurant Group (FWRG) — Citigroup maintained its Buy rating.
F.N.B. (FNB) — Raymond James set a US$20.00 price target.
Fortinet (FTNT) — Arete downgraded the stock to Sell from Buy and set a US$117.00 price target.
Freshpet (FRPT) — Deutsche Bank set a US$67.00 price target.
GE Aerospace (GE) — BNP Paribas Exane maintained its Underperform rating and lowered its price target to US$280.00 from US$305.00.
GE Aerospace (GE) — Deutsche Bank maintained its Buy rating and set a US$378.00 price target.
GE Aerospace (GE) — Guggenheim set a US$380.00 price target.
GE Aerospace (GE) — H.C. Wainwright set a US$375.00 price target.
GE Aerospace (GE) — JPMorgan maintained its Overweight rating and lowered its price target to US$375.00 from US$400.00.
GE Aerospace (GE) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$375.00 from US$400.00.
GE Aerospace (GE) — RBC Capital Markets maintained its Outperform rating and lowered its price target to US$375.00 from US$400.00.
GE Aerospace (GE) — Susquehanna maintained its Positive rating and lowered its price target to US$400.00 from US$430.00.
General Motors (GM) — Barclays maintained its Overweight rating and lowered its price target to US$105.00 from US$110.00.
General Motors (GM) — Deutsche Bank set a US$98.00 price target.
General Motors (GM) — Goldman Sachs maintained its Buy rating and lowered its price target to US$96.00 from US$112.00.
General Motors (GM) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$95.00 from US$101.00.
General Motors (GM) — RBC Capital Markets maintained its Outperform rating and lowered its price target to US$98.00 from US$102.00.
General Motors (GM) — TD Cowen maintained its Buy rating and set a US$132.00 price target.
General Motors (GM) — UBS maintained its Buy rating and set a US$109.00 price target.
Genuine Parts (GPC) — UBS maintained its Neutral rating.
GFL Environmental (GFL) — JPMorgan maintained its Underweight rating and raised its price target to US$42.00 from US$41.00.
Halliburton (HAL) — Barclays maintained its Overweight rating and lowered its price target to US$51.00 from US$53.00.
Halliburton (HAL) — Jefferies maintained its Buy rating and raised its price target to US$48.00 from US$47.00.
Halliburton (HAL) — RBC Capital Markets maintained its Outperform rating and raised its price target to US$46.00 from US$45.00.
Hancock Whitney (HWC) — Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to US$79.00 from US$80.00.
Hancock Whitney (HWC) — Piper Sandler maintained its Overweight rating and raised its price target to US$88.00 from US$87.00.
Hancock Whitney (HWC) — Raymond James maintained its Strong Buy rating.
Hasbro (HAS) — BNP Paribas Exane maintained its Outperform rating and raised its price target to US$127.00 from US$116.00.
Hasbro (HAS) — Roth Capital maintained its Buy rating.
Hasbro (HAS) — UBS set a US$125.00 price target.
Hasbro (HAS) — Wells Fargo maintained its Equal Weight rating and raised its price target to US$100.00 from US$90.00.
H. B. Fuller (FUL) — UBS maintained its Neutral rating and set a US$55.00 price target.
HealthEquity (HQY) — BMO Capital Markets maintained its Outperform rating and raised its price target to US$125.00 from US$105.00.
Hilton Worldwide (HLT) — JPMorgan maintained its Overweight rating and raised its price target to US$387.00 from US$365.00.
Home Bancorp (HBCP) — Piper Sandler maintained its Neutral rating and lowered its price target to US$64.00 from US$71.00.
Home Bancorp (HBCP) — Raymond James set a US$66.00 price target.
Hyatt Hotels (H) — JPMorgan maintained its Overweight rating and lowered its price target to US$207.00 from US$209.00.
IDACORP (IDA) — Morgan Stanley maintained its Overweight rating and raised its price target to US$144.00 from US$143.00.
IDEX (IEX) — Oppenheimer maintained its Outperform rating and raised its price target to US$275.00 from US$270.00.
Incyte (INCY) — TD Cowen maintained its Buy rating and raised its price target to US$140.00 from US$138.00.
Insmed (INSM) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$213.00 from US$218.00.
Intel (INTC) — Susquehanna maintained its Neutral rating and lowered its price target to US$105.00 from US$115.00.
Intuitive Surgical (ISRG) — Baird maintained its Outperform rating and raised its price target to US$550.00 from US$513.00.
Intuitive Surgical (ISRG) — Barclays maintained its Overweight rating and raised its price target to US$500.00 from US$485.00.
Intuitive Surgical (ISRG) — BTIG Research maintained its Buy rating and set a US$454.00 price target.
Intuitive Surgical (ISRG) — Erste Group upgraded the stock to Buy from Hold.
Intuitive Surgical (ISRG) — JPMorgan maintained its Overweight rating and raised its price target to US$475.00 from US$450.00.
Intuitive Surgical (ISRG) — Leerink Partners set a US$503.00 price target.
Intuitive Surgical (ISRG) — Mizuho maintained its Neutral rating and lowered its price target to US$400.00 from US$415.00.
Intuitive Surgical (ISRG) — Oppenheimer maintained its Outperform rating and set a US$500.00 price target.
Intuitive Surgical (ISRG) — Raymond James maintained its Outperform rating and set a US$480.00 price target.
Intuitive Surgical (ISRG) — RBC Capital Markets maintained its Outperform rating and lowered its price target to US$550.00 from US$575.00.
Intuitive Surgical (ISRG) — Wells Fargo maintained its Overweight rating and lowered its price target to US$486.00 from US$487.00.
Ionis Pharmaceuticals (IONS) — Citigroup maintained its Buy rating.
Jazz Pharmaceuticals (JAZZ) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$314.00 from US$322.00.
JFrog (FROG) — Truist Securities maintained its Buy rating and raised its price target to US$115.00 from US$110.00.
Johnson & Johnson (JNJ) — Erste Group downgraded the stock to Hold from Buy.
Johnson & Johnson (JNJ) — Johnson Rice downgraded the stock to Hold from Buy.
Kazia Therapeutics (KZIA) — Guggenheim initiated coverage with a Buy rating and set a US$35.00 price target.
KeyCorp (KEY) — D.A. Davidson maintained its Buy rating and raised its price target to US$27.00 from US$26.00.
KeyCorp (KEY) — RBC Capital Markets maintained its Outperform rating and lowered its price target to US$24.00 from US$25.00.
Kinetik (KNTK) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$67.00 from US$70.00.
Knowles (KN) — Susquehanna maintained its Neutral rating and lowered its price target to US$35.00 from US$40.00.
Kroger (KR) — Deutsche Bank maintained its Buy rating and set a US$70.00 price target.
Kroger (KR) — Guggenheim maintained its Buy rating and raised its price target to US$68.00 from US$66.00.
Kroger (KR) — UBS maintained its Outperform rating and set a US$66.00 price target.
Kroger (KR) — Wells Fargo maintained its Equal Weight rating and raised its price target to US$60.00 from US$58.00.
Las Vegas Sands (LVS) — Susquehanna maintained its Positive rating and lowered its price target to US$51.00 from US$63.00.
Lyft (LYFT) — TD Cowen maintained its Buy rating and lowered its price target to US$26.00 from US$30.00.
Magna International (MGA) — CIBC downgraded the stock to Neutral from Outperformer and lowered its price target to US$70.00 from US$78.00.
Marriott International (MAR) — JPMorgan maintained its Neutral rating and raised its price target to US$406.00 from US$388.00.
Mercantile Bank (MBWM) — Keefe, Bruyette & Woods maintained its Outperform rating and raised its price target to US$65.00 from US$64.00.
MetLife (MET) — TD Cowen maintained its Buy rating and raised its price target to US$114.00 from US$110.00.
MGE Energy (MGEE) — Morgan Stanley maintained its Underweight rating and raised its price target to US$72.00 from US$71.00.
Microbot Medical (MBOT) — H.C. Wainwright maintained its Buy rating and set a US$12.00 price target.
Microsoft (MSFT) — Guggenheim maintained its Buy rating and set a US$586.00 price target.
Mid-America Apartment Communities (MAA) — Goldman Sachs maintained its Neutral rating and lowered its price target to US$125.00 from US$142.00.
MiNK Therapeutics (INKT) — B. Riley Securities maintained its Buy rating and raised its price target to US$50.00 from US$43.00.
Mirum Pharmaceuticals (MIRM) — TD Cowen maintained its Buy rating and raised its price target to US$145.00 from US$140.00.
Mission Produce (AVO) — Santander initiated coverage with an Outperform rating.
Mobileye Global (MBLY) — RBC Capital Markets downgraded the stock to Underperform from Sector Perform and lowered its price target to US$5.00 from US$7.00.
MSCI (MSCI) — Jefferies maintained its Buy rating and set a US$680.00 price target.
MSCI (MSCI) — JPMorgan maintained its Overweight rating and raised its price target to US$710.00 from US$685.00.
MSCI (MSCI) — Morgan Stanley maintained its Overweight rating and raised its price target to US$671.00 from US$662.00.
MSCI (MSCI) — RBC Capital Markets maintained its Outperform rating and set a US$655.00 price target.
MSCI (MSCI) — Wells Fargo maintained its Overweight rating and raised its price target to US$720.00 from US$685.00.
M&T Bank (MTB) — Citigroup maintained its Neutral rating.
Nebius Group (NBIS) — Piper Sandler maintained its Neutral rating and lowered its price target to US$185.00 from US$237.00.
Neptune Insurance (NP) — Mizuho maintained its Neutral rating and raised its price target to US$33.00 from US$31.00.
Netflix (NFLX) — Barclays maintained its Equal Weight rating and lowered its price target to US$65.00 from US$70.00.
Netflix (NFLX) — Bernstein maintained its Outperform rating and lowered its price target to US$80.00 from US$95.00.
Netflix (NFLX) — BofA Securities maintained its Buy rating and lowered its price target to US$90.00 from US$105.00.
Netflix (NFLX) — Canaccord Genuity set a US$110.00 price target.
Netflix (NFLX) — Citigroup maintained its Buy rating.
Netflix (NFLX) — Citizens JMP maintained its Market Perform rating.
Netflix (NFLX) — Deutsche Bank set a US$93.00 price target.
Netflix (NFLX) — Evercore ISI maintained its Outperform rating and set a US$90.00 price target.
Netflix (NFLX) — Goldman Sachs set a US$84.00 price target.
Netflix (NFLX) — Guggenheim maintained its Buy rating and lowered its price target to US$78.00 from US$80.00.
Netflix (NFLX) — JPMorgan maintained its Overweight rating and lowered its price target to US$81.00 from US$85.00.
Netflix (NFLX) — Moffett Nathanson maintained its Buy rating and set a US$90.00 price target.
Netflix (NFLX) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$77.00 from US$80.00.
Netflix (NFLX) — Needham downgraded the stock to Hold from Buy.
Netflix (NFLX) — Oppenheimer maintained its Outperform rating and lowered its price target to US$80.00 from US$85.00.
Netflix (NFLX) — Piper Sandler maintained its Overweight rating and lowered its price target to US$78.00 from US$85.00.
Netflix (NFLX) — Pivotal Research maintained its Hold rating and set a US$65.00 price target.
Netflix (NFLX) — Rosenblatt maintained its Neutral rating and lowered its price target to US$71.00 from US$75.00.
Netflix (NFLX) — TD Cowen maintained its Buy rating and set a US$100.00 price target.
Netflix (NFLX) — UBS maintained its Reduce rating and set a US$90.00 price target.
Netflix (NFLX) — William Blair maintained its Outperform rating.
NetSol Technologies (NTWK) — Noble Capital Markets initiated coverage with an Outperform rating and set a US$9.00 price target.
NextEra Energy (NEE) — Bernstein maintained its Outperform rating and set a US$108.00 price target.
Nextpower (NXT) — BMO Capital Markets maintained its Outperform rating and lowered its price target to US$114.00 from US$132.00.
Nexxen International (NEXN) — BTIG Research maintained its Buy rating and set a US$13.00 price target.
Nicolet Bankshares (NIC) — Piper Sandler maintained its Overweight rating and raised its price target to US$196.00 from US$194.00.
NiSource (NI) — Citigroup maintained its Buy rating.
Northrop Grumman (NOC) — Baird upgraded the stock to Outperform from Neutral and raised its price target to US$675.00 from US$550.00.
Northrop Grumman (NOC) — BNP Paribas Exane maintained its Outperform rating and raised its price target to US$600.00 from US$540.00.
Northrop Grumman (NOC) — Guggenheim maintained its Buy rating and raised its price target to US$640.00 from US$612.00.
Northrop Grumman (NOC) — Morgan Stanley maintained its Overweight rating and raised its price target to US$765.00 from US$745.00.
Northrop Grumman (NOC) — RBC Capital Markets maintained its Sector Perform rating and raised its price target to US$550.00 from US$525.00.
Northrop Grumman (NOC) — UBS maintained its Buy rating and set a US$698.00 price target.
NRG Energy (NRG) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$144.00 from US$159.00.
NRG Energy (NRG) — Raymond James maintained its Strong Buy rating and set a US$152.00 price target.
NRG Energy (NRG) — UBS maintained its Strong Buy rating and set a US$152.00 price target.
NRG Energy (NRG) — Williams Trading set a US$165.00 price target.
NuScale Power (SMR) — Citigroup maintained its Sell rating.
Oculis (OCS) — H.C. Wainwright maintained its Buy rating.
OGE Energy (OGE) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$47.00 from US$46.00.
ONE Gas (OGS) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$78.00 from US$79.00.
ONEOK (OKE) — RBC Capital Markets maintained its Sector Perform rating and raised its price target to US$96.00 from US$90.00.
onsemi (ON) — Susquehanna maintained its Positive rating and lowered its price target to US$120.00 from US$150.00.
Pacific Gas & Electric (PCG) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$21.00 from US$20.00.
Palisade Bio (PALI) — Oppenheimer maintained its Outperform rating.
Park Hotels & Resorts (PK) — JPMorgan maintained its Underweight rating and raised its price target to US$16.00 from US$14.00.
Pegasystems (PEGA) — Citigroup maintained its Market Perform rating.
Pegasystems (PEGA) — UBS downgraded the stock to Sell.
Pentair (PNR) — Oppenheimer maintained its Outperform rating and lowered its price target to US$84.00 from US$94.00.
Phathom Pharmaceuticals (PHAT) — Craig Hallum maintained its Buy rating and set a US$15.00 price target.
Pinnacle West Capital (PNW) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$91.00 from US$89.00.
Power Integrations (POWI) — Susquehanna maintained its Positive rating and lowered its price target to US$70.00 from US$85.00.
PPL (PPL) — Morgan Stanley maintained its Overweight rating and raised its price target to US$40.00 from US$39.00.
Prologis (PLD) — Raymond James upgraded the stock to Outperform from Market Perform and set a US$163.00 price target.
Protagonist Therapeutics (PTGX) — TD Cowen maintained its Buy rating and raised its price target to US$160.00 from US$155.00.
Prudential Financial (PRU) — TD Cowen maintained its Hold rating and lowered its price target to US$112.00 from US$114.00.
Public Service Enterprise Group (PEG) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$85.00 from US$88.00.
Qualcomm (QCOM) — Susquehanna maintained its Neutral rating and raised its price target to US$185.00 from US$160.00.
QumulusAI (QMLS) — B. Riley Securities initiated coverage with a Buy rating and set a US$11.00 price target.
Rapport Therapeutics (RAPP) — JonesTrading maintained its Buy rating and raised its price target to US$82.00 from US$50.00.
Rapport Therapeutics (RAPP) — Wells Fargo maintained its Overweight rating and lowered its price target to US$50.00 from US$51.00.
Real REMAX Group (REAX) — Zelman & Associates downgraded the stock to Neutral from Outperform.
Regeneron Pharmaceuticals (REGN) — TD Cowen maintained its Buy rating and raised its price target to US$980.00 from US$960.00.
Regions Financial (RF) — Cantor Fitzgerald maintained its Overweight rating and set a US$32.00 price target.
Reinsurance Group of America (RGA) — TD Cowen maintained its Hold rating and raised its price target to US$250.00 from US$235.00.
Revolution Medicines (RVMD) — TD Cowen maintained its Buy rating and set a US$250.00 price target.
RLI (RLI) — Keefe, Bruyette & Woods maintained its Outperform rating.
RLI (RLI) — Wells Fargo maintained its Underweight rating and raised its price target to US$53.00 from US$51.00.
Robinhood Markets (HOOD) — Needham maintained its Buy rating and raised its price target to US$126.00 from US$123.00.
Robinhood Markets (HOOD) — Rosenblatt initiated coverage with a Buy rating and set a US$135.00 price target.
RTX (RTX) — Barclays maintained its Overweight rating and raised its price target to US$235.00 from US$223.00.
RTX (RTX) — UBS maintained its Neutral rating and set a US$212.00 price target.
Ryman Hospitality Properties (RHP) — JPMorgan maintained its Overweight rating and raised its price target to US$138.00 from US$129.00.
Salesforce (CRM) — Cantor Fitzgerald maintained its Overweight rating and set a US$300.00 price target.
Salesforce (CRM) — D.A. Davidson maintained its Neutral rating and raised its price target to US$250.00 from US$225.00.
Seagate Technology (STX) — BofA Securities maintained its Buy rating and raised its price target to US$1,200.00 from US$1,150.00.
Selective Insurance Group (SIGI) — BMO Capital Markets maintained its Market Perform rating.
ServiceNow (NOW) — Truist Securities maintained its Buy rating and raised its price target to US$180.00 from US$130.00.
Shake Shack (SHAK) — Wells Fargo maintained its Equal Weight rating and raised its price target to US$70.00 from US$65.00.
Silence Therapeutics (SLN) — H.C. Wainwright downgraded the stock to Neutral from Buy and lowered its price target to US$20.00 from US$75.00.
Six Flags Entertainment (FUN) — Guggenheim maintained its Buy rating and lowered its price target to US$17.00 from US$28.00.
Six Flags Entertainment (FUN) — Mizuho set a US$5.00 price target.
Skyworks Solutions (SWKS) — Susquehanna maintained its Neutral rating and raised its price target to US$90.00 from US$65.00.
SmartFinancial (SMBK) — Raymond James downgraded the stock to Outperform from Strong Buy and lowered its price target to US$56.00 from US$58.00.
SM Energy (SM) — Raymond James maintained its Outperform rating and set a US$50.00 price target.
SolarEdge Technologies (SEDG) — BMO Capital Markets maintained its Underperform rating and lowered its price target to US$28.00 from US$31.00.
Solaris Energy Infrastructure (SEI) — Morgan Stanley maintained its Overweight rating and raised its price target to US$102.00 from US$90.00.
Solstice Advanced Materials (SOLS) — BMO Capital Markets maintained its Outperform rating and set a US$87.00 price target.
Southern (SO) — BMO Capital Markets maintained its Outperform rating.
Southern (SO) — D.A. Davidson set a US$98.00 price target.
Southern (SO) — Morgan Stanley maintained its Underweight rating and lowered its price target to US$84.00 from US$85.00.
SpaceX (SPCX) — Barclays maintained its Overweight rating and set a US$300.00 price target.
SpaceX (SPCX) — Bernstein maintained its Outperform rating.
SpaceX (SPCX) — Citigroup maintained its Buy rating.
SpaceX (SPCX) — Goldman Sachs maintained its Buy rating and set a US$245.00 price target.
SpaceX (SPCX) — JPMorgan maintained its Overweight rating and raised its price target to US$500.00 from US$240.00.
SpaceX (SPCX) — KeyCorp maintained its Sector Weight rating.
SpaceX (SPCX) — Mizuho set a US$205.00 price target.
SpaceX (SPCX) — Morgan Stanley maintained its Overweight rating.
SpaceX (SPCX) — Needham maintained its Buy rating and set a US$250.00 price target.
SpaceX (SPCX) — Piper Sandler maintained its Neutral rating.
SpaceX (SPCX) — Pivotal Research set a US$260.00 price target.
SpaceX (SPCX) — Susquehanna maintained its Neutral rating and raised its price target to US$176.00 from US$173.00.
SpaceX (SPCX) — TD Cowen maintained its Buy rating and raised its price target to US$224.00 from US$200.00.
SpaceX (SPCX) — Wells Fargo maintained its Overweight rating and raised its price target to US$274.00 from US$214.00.
Sphere Entertainment (SPHR) — Susquehanna maintained its Positive rating and lowered its price target to US$158.00 from US$182.00.
SPX Technologies (SPXC) — Oppenheimer maintained its Outperform rating and lowered its price target to US$265.00 from US$270.00.
Spyglass Pharma (SGP) — H.C. Wainwright maintained its Buy rating and set a US$37.00 price target.
Starbucks (SBUX) — Wells Fargo maintained its Overweight rating and lowered its price target to US$120.00 from US$125.00.
Steel Dynamics (STLD) — Wells Fargo maintained its Overweight rating and raised its price target to US$271.00 from US$257.00.
Stem (STEM) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to US$5.00 from US$8.00.
Sunstone Hotel Investors (SHO) — JPMorgan maintained its Underweight rating and raised its price target to US$11.00 from US$10.00.
Sweetgreen (SG) — TD Cowen maintained its Hold rating and raised its price target to US$9.00 from US$6.00.
Synchrony Financial (SYF) — Barclays maintained its Overweight rating and raised its price target to US$94.00 from US$93.00.
Synchrony Financial (SYF) — Evercore ISI downgraded the stock to In-line from Outperform and set a US$78.00 price target.
Synchrony Financial (SYF) — JPMorgan maintained its Neutral rating and raised its price target to US$77.00 from US$74.00.
Talen Energy (TLN) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$504.00 from US$514.00.
Targa Resources (TRGP) — BMO Capital Markets maintained its Outperform rating and raised its price target to US$328.00 from US$303.00.
Telix Pharmaceuticals (TLX) — Wedbush maintained its Outperform rating and set a US$22.00 price target.
Terrestrial Energy (IMSR) — Lake Street initiated coverage with a Buy rating and set a US$15.00 price target.
Tesla (TSLA) — Citigroup maintained its Neutral rating.
TKO Group (TKO) — BTIG Research maintained its Buy rating and set a US$237.00 price target.
Transcat (TRNS) — Northland Capital upgraded the stock to Outperform from Market Perform and set a US$95.00 price target.
TransUnion (TRU) — UBS maintained its Neutral rating and set a US$83.00 price target.
Truist Financial (TFC) — Citigroup maintained its Neutral rating.
Twilio (TWLO) — Oppenheimer maintained its Outperform rating and raised its price target to US$325.00 from US$275.00.
United Airlines (UAL) — Evercore ISI maintained its Outperform rating and set a US$160.00 price target.
United Community Banks (UCB) — Stephens maintained its Overweight rating and raised its price target to US$42.00 from US$41.00.
United Parcel Service (UPS) — Bernstein maintained its Outperform rating and lowered its price target to US$127.00 from US$131.00.
Valvoline (VVV) — RBC Capital Markets maintained its Outperform rating and lowered its price target to US$46.00 from US$49.00.
Vicor (VICR) — Roth Capital set a US$360.00 price target.
Vistra (VST) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$226.00 from US$227.00.
Vistra (VST) — Raymond James maintained its Strong Buy rating and set a US$176.00 price target.
Vistra (VST) — UBS set a US$176.00 price target.
Vor Biopharma (VOR) — William Blair initiated coverage with an Outperform rating.
Western Alliance Bancorporation (WAL) — JPMorgan maintained its Neutral rating and lowered its price target to US$85.00 from US$90.00.
Western Digital (WDC) — BofA Securities maintained its Buy rating and raised its price target to US$800.00 from US$720.00.
Western Midstream Partners (WES) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$52.00 from US$55.00.
Wintrust Financial (WTFC) — Piper Sandler maintained its Overweight rating and lowered its price target to US$186.00 from US$195.00.
Wintrust Financial (WTFC) — Raymond James set a US$165.00 price target.
Wintrust Financial (WTFC) — TD Cowen maintained its Buy rating and raised its price target to US$174.00 from US$173.00.
Wolfspeed (WOLF) — Susquehanna maintained its Neutral rating and lowered its price target to US$25.00 from US$30.00.
Xcel Energy (XEL) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$85.00 from US$83.00.
Xencor (XNCR) — Wedbush maintained its Outperform rating and set a US$30.00 price target.
X-Energy (XE) — UBS maintained its Buy rating and set a US$18.00 price target.
Xilio Therapeutics (XLO) — Raymond James initiated coverage with an Outperform rating and set a US$16.00 price target.
Yum! Brands (YUM) — Deutsche Bank maintained its Hold rating and set a US$167.00 price target.
Zions Bancorporation (ZION) — Piper Sandler maintained its Neutral rating and raised its price target to US$69.00 from US$68.00.
Zoom Communications (ZM) — BTIG Research maintained its Buy rating and set a US$125.00 price target.
Zoom Communications (ZM) — Cantor Fitzgerald maintained its Neutral rating and set a US$104.00 price target.
Zoom Communications (ZM) — Oppenheimer upgraded the stock to Outperform from Market Perform and set a US$130.00 price target.
Zoom Communications (ZM) — RBC Capital Markets maintained its Outperform rating and set a US$130.00 price target.
Zoom Communications (ZM) — Rosenblatt maintained its Buy rating and set a US$130.00 price target.
Zoom Communications (ZM) — UBS maintained its Neutral rating and set a US$112.00 price target.
Zscaler (ZS) — D.A. Davidson initiated coverage with a Neutral rating and set a US$215.00 price target.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.
Related research
How Trump’s Tariffs Could Shake Up Magna International’s Auto Parts Business
STA Research (Rank#25) Maintained “Hold” Rating on Starbucks, $110 target (SBUX:NSD)
Bank of Canada Looks to Pause rates as Recession Looms
US Analyst Updates — October 20th, 2026
US Analyst Updates: October 19th, 2026
US Analyst Updates: October 16th, 2026
A monthly perspective in your inbox.
Five research sections in the STA Research Professional Newsletter.